DianeMHarperMDMPH MS

Family Medicine • Ann Arbor, MI

Women's Health

Rowntree Endowed Chair and Professor, Department of Family and Geriatric Medicine, Obstetrics and Gynecology, Bioengineering, Epidemiology and Population Health; Health Promotion and Behavioral Health Sciences

Join to view full profile

Dr. Harper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harper's full profile

Already have an account?

Office
‎1500 E Medical Center Dr .
Ann Arbor, MI 48109
Phone+1 800-865-1125

Education & Training

University of Kansas School of Public HealthMPH, Epidemiology and Biostatistics, 1993 - 1995
University of Kansas School of MedicineResidency, Family Medicine, 1987 - 1990
University of Kansas School of MedicineResidency, Obstetrics and Gynecology, 1986 - 1986
University of Kansas School of MedicineClass of 1986
Massachusetts Institute of TechnologyMS, Chemical Engineering, 1980 - 1982

Certifications & Licensure

MI State Medical License 2018 - 2026
KS State Medical License 1987 - 2025
KY State Medical License 2014 - 2021
MO State Medical License 1990 - 2021
NH State Medical License 1996 - 2020
VT State Medical License 1996 - 2020
American Board of Family Medicine Family Medicine

Publications & Presentations

PubMed

116 citations
Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.
Fernanda Tavares Da Silva, Bernard Gonik, Mark McMillan, Cheryl Keech, Stephanie Dellicour
Vaccine. 2016-12-01
664 citations
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
, Karina W Davidson, Michael J Barry, Carol M Mangione, Michael Cabana
JAMA. 2021-05-18
369 citations
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a ...
Elmar A. Joura, Sepp Leodolter, Mauricio Hernández-Ávila, Cosette M. Wheeler, Gonzalo Perez
Lancet. 2007-05-19

Press Mentions

No Evidence of Link Between Vaccine and Ovary DamageApril 23rd, 2023
Why Some HPV Infections Carry More Cervical Cancer RiskFebruary 2nd, 2023
Despite HPV Vaccine, Cervical Cancer Rates Keep RisingDecember 23rd, 2022
Join now to see all

Committees

Member, U.S. Preventive Services Task Force (USPSTF) 2016 - 2018